Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD64 antibody variable domain is fused to CH1 and the other scFv from an anti-malaria antigen antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY